Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

287.93 -0.89 (-0.31%)

Streaming Delayed Price Updated: 10:54 AM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

18 19 Next >

Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

September 24, 2024

Via Benzinga

Analyst Expectations For Insulet's Future ↗

September 17, 2024

Via Benzinga

GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 17, 2024

Via Benzinga

Upstart, Insulet And 2 Other Stocks Executives Are Selling ↗

September 12, 2024

Via Benzinga

Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today ↗

September 10, 2024

Via Benzinga

Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio? ↗

September 02, 2024

Top-performing large-cap stocks from last week: AFRM, NTNX, MDB, BBY, GEV, TCOM, COO, PODD, VEEV, AZPN.

Via Benzinga

(PODD) - Analyzing Insulet's Short Interest ↗

August 30, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years ↗

August 28, 2024

Via Benzinga

Why Insulet Stock Was Zooming Higher This Week ↗

August 30, 2024

The company had encouraging news to impart about its leading insulin pump.

Via The Motley Fool

Stocks To Watch Today: PODD, SMCI, And PAYC ↗

August 27, 2024

Insulet Corporation surged on FDA approval for its diabetes treatment device, while SMCI faced pressure from a short-seller report, and Paycom Software saw insider selling activity.

Via Talk Markets

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

August 26, 2024

From Insulet Corporation

Via Business Wire

S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday? ↗

August 20, 2024

S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest.

Via Benzinga

Topics Stocks

The Latest Analyst Ratings For Insulet ↗

August 12, 2024

Via Benzinga

Peering Into Insulet's Recent Short Interest ↗

August 12, 2024

Via Benzinga

Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

August 08, 2024

INSULET CORP (NASDAQ:PODD)—A High-Growth Stock Gearing Up for Its Next Upward Move.

Via Chartmill

Insulet to Present at Upcoming Investor Conferences

August 20, 2024

From Insulet Corporation

Via Business Wire

Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia

August 14, 2024

From Insulet Corporation

Via Business Wire

Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday? ↗

August 09, 2024

After a blistering Thursday that saw the S&P 500 close with its best session in nearly two years — up 2.3% — Wall Street’s price action turned sluggish on a Friday lacking market-moving economic...

Via Benzinga

Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today ↗

August 07, 2024

Via Benzinga

A Closer Look at 7 Analyst Recommendations For Insulet ↗

July 23, 2024

Via Benzinga

Stocks On Track For Weekly Losses Despite Midday Gains ↗

August 09, 2024

The Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 Index are attempting to pare this morning's losses as they move into positive territory for the afternoon.

Via Talk Markets

Topics Stocks

Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst ↗

August 09, 2024

Insulet reported a Q2 adjusted EPS of $0.55, slightly missing estimates but showing strong sales growth of 23.2% year-over-year, driven by Omnipod revenue. The company raised its 2024 revenue guidance,...

Via Benzinga

PODD Stock Earnings: Insulet Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

PODD stock results show that Insulet missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year

August 08, 2024

From Insulet Corporation

Via Business Wire

Wall Street Set For Uneventful Start Ahead Of Jobless Claim Data, VIX Rises: Strategist Says Market May Remain Vulnerable Until... ↗

August 08, 2024

U.S. stocks are set for a mixed start on Thursday as concerns regarding the economy and incremental yen carry trade unwinding remain an undercurrent. Traders may be keen to receive the jobless claims...

Via Benzinga

Topics Economy Stocks

Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday? ↗

August 08, 2024

Investor risk sentiment is showing greater conviction on Thursday, with all indices and major stock sectors in the green, after Wall Street failed to hold onto opening gains and closed in the red the...

Via Benzinga

Chips, Glorious Chips! ↗

August 07, 2024

Someone's gotta make 'em, and someone's gotta buy 'em.

Via The Motley Fool

$1000 Invested In This Stock 15 Years Ago Would Be Worth $26,000 Today ↗

July 19, 2024

Via Benzinga

Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today? ↗

July 26, 2024

Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook.

Via Benzinga

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

July 26, 2024

From Insulet Corporation

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.